A novel GLP-1 analog, BPI3006, with potent DPP IV resistance and good glucoregulatory effect-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel GLP-1 analog, BPI3006, with potent DPP IV resistance and good glucoregulatory effect

Published:2010-10 Issue:4 Volume:400 Page:563-568
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Li Caina,Huan Yi,Shen Ning,Ji Lixia,Sun Sujuan,Liu Shuainan,Liu Quan,Gao Lihui,Tan Fenlai,Wang Yanping,Shen Zhufang

Funder

Chinese National Science and Technology Innovation Fund of small and medium enterprises

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. Glucagon-like peptide-1-based therapies: new developments and emerging data;Garber;Diabetes Obes. Metab.,2008

2. Glucagon-like peptide-I 7-36: a physiological incretin in man;Kreymann;Lancet,1987

3. Glucagon-like peptide-1 (7-36) amide and glucose dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute postprandial and 24h secretion patterns;Elliott;J. Endocrinol.,1993

4. Tissue distribution of messenger ribonucleic acid encoding the rat glucagons-like peptide-1 receptor;Bullock;Endocrinology,1996

5. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1;Thorens;Proc. Natl. Acad. Sci. USA,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained release of GLP-1 analog from γ-PGA-PAE copolymers for management of type 2 diabetes;Biomaterials Advances;2023-05

2. Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists;Pharmaceuticals;2022-06-13

3. Rational design by structural biology of industrializable, long-acting antihyperglycemic GLP-1 receptor agonists;2022-04-11

4. Antidiabetic effect of an engineered bacterium Lactobacillus plantarum-pMG36e -GLP-1 in monkey model;Synthetic and Systems Biotechnology;2021-12

5. Drug discovery approaches targeting the incretin pathway;Bioorganic Chemistry;2020-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3